Open Access Article
Hamada Mohamed Ibrahim
*a,
Haider Behbehani*b and
Wael Abdelgayed Ahmed Arafa
ac
aChemistry Department, Faculty of Science, Fayoum University, P.O. Box 63514, Fayoum, Egypt. E-mail: hmi00@fayoum.edu.eg; hamadaaldeb@yahoo.com
bChemistry Department, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait. E-mail: drhaider.b@gmail.com
cChemistry Department, College of Science, Jouf University, P.O. Box 2014, Sakaka, Aljouf, Kingdom of Saudi Arabia
First published on 20th April 2020
A facile and effective assembly of several substituted functionalized mono- and bis-[1,2,4]triazolo[1,5-a]pyridines from conveniently attainable 1-amino-2-imino-pyridines has been established. Using microwave irradiation speeds up the reaction efficiently, proceeding with a higher rate and yields than with conventional heating. In the presented protocol, a broad variety of carboxylic acids could be employed effectively to synthesize the respective derivatives via direct metal-free C–N bond construction. Interestingly, other substrates such as aldehydes (or their arylidene malononitriles), phenyl isothiocyanate, glyoxalic acid, and acrylonitriles could also provide the corresponding 1,2,4-triazolo[1,5-a]pyridines successfully. This versatile and convergent approach performs well with both deactivating and activating substrates in an environmentally benign manner compared with other already reported protocols. Other notable merits of the current strategy involve no need for column chromatography, no tedious work-up, and a direct pathway for the fast design of triazolopyridine frameworks. The identity of the newly synthesized compounds was established using several spectroscopic techniques, and X-ray single-crystal tools were employed to authenticate the suggested structures of some representative samples.
![]() | ||
| Scheme 1 Synthesis of 1-amino-2-imino-pyridines 3a–e.33 | ||
Our initial investigation commenced by the reaction of 1-amino-2-imino-pyridine derivative (3a) with acetic acid (as a solvent and reactant) at reflux for 3 h. Interestingly, the formation of the required product (5a) has been detected, albeit in a good yield of 74%, as a preliminary endeavor (Table 1, entry 1). Encouraged by the obtained results, the reaction conditions such as solvents, energy sources, and temperature have been evaluated to improve both reaction rate and yield (Table 1). Thereby, the reaction of 3a with acetic acid (1 equiv.) was investigated utilizing various solvents such as polar protic (EtOH, MeOH, and propanol), polar aprotic (CH3CN, and dioxane), and nonpolar (toluene) solvents at different times using various energy sources (heating, US, and MW irradiations). Unfortunately, none of them could afford the required product (Table 1, entries 2–13). Then the model reaction (Table 1) was also examined in 10.0 mL of ethanol comprising 5 equiv. of acetic acid to investigate its efficiency in the production of derivative 5a. Interestingly, compound 5a was crystalline out from the reaction mixture in 3 h of refluxing in 80% yield (Table 1, entry 14). Next, the molar ratio of acetic acid employed has also assessed. It was found that employing a mixture of ethanol/acetic acid (10 equiv.), not only improved the reaction yield to 85% but also provided a cleaner and lighter color product (Table 1, entry 15). Increasing the equivalents of acetic acid more than 10 equiv., neither improves the reaction rate nor the yield (Table 1, entry 16). Due to the versatility, efficiency, and selectivity of microwave irradiation, the model reaction (Scheme 1) was also investigated under the microwave irradiation conditions. The required product 5a was obtained in 89% in 25 min under microwave irradiation at 80 °C (Table 1, entry 17). On reducing the reaction duration to 15 min and increasing the temperature to 100 °C, the isolated yield was enhanced to be 92% (Table 1, entry 18). Increasing the temperature more than 100 °C did not improve the reaction (Table 1, entry 19). Thus, employing the model reaction (Table 1) using 3.0 mmol of derivative 3a in ethanol (10.0 mL) containing acetic acid (10 equiv.) and irradiation under microwave for 15 min at 100 °C has been identified as the optimal conditions (Table 1, entry 18). A reasonable reaction mechanism for the synthesis of 1,2,4-triazole derivative (5a) was described in Table 1, based on experimental evidences and our reported studies.31–33 As outlined in Table 1, the transformation of the non-isolable intermediate (A) to the target compound (5a) occurred under metal-free conditions.
| Entry | Solvent | Method | Time | Yield (%) |
|---|---|---|---|---|
| a Reaction conditions: a mixture of 1-amino-2(1H)-pyridine-2-imine derivatives (3a) (3.0 mmol) and acetic acid 4a (as reported) in solvent (10.0 mL) was heated or irradiated by microwave or ultrasound for the given time.b NR: no reaction. | ||||
| 1 | AcOH | Heating | 3 h | 74 |
| 2 | EtOH | Heating | 12 h | NRb |
| 3 | EtOH | MW | 45 min | NR |
| 4 | MeOH | Heating | 12 h | NR |
| 5 | MeOH | MW | 45 min | NR |
| 6 | CH3CN | Heating | 12 h | NR |
| 7 | CH3CN | MW | 45 min | NR |
| 8 | Propanol | Heating | 12 h | NR |
| 9 | Propanol | MW | 45 min | NR |
| 10 | 1,4-Dioxane | Heating | 12 h | NR |
| 11 | 1,4-Dioxane | MW | 45 min | NR |
| 12 | Toluene | Heating | 12 h | NR |
| 13 | Toluene | US | 45 min (80 °C) | NR |
| 14 | EtOH/AcOH (5 equiv.) | Heating | 3 h | 80 |
| 15 | EtOH/AcOH (10 equiv.) | Heating | 3 h | 85 |
| 16 | EtOH/AcOH (15 equiv.) | Heating | 3 h | 85 |
| 17 | EtOH/AcOH (10 equiv.) | MW | 25 min (80 °C, 250 W) | 89 |
| 18 | EtOH/AcOH (10 equiv.) | MW | 15 min (100 °C, 250 W) | 92 |
| 19 | EtOH/AcOH (10 equiv.) | MW | 15 min (120 °C, 250 W) | 92 |
Now, the limitations and scope of the aforesaid reaction have then investigated. Therefore the reaction of 1-amino-2(1H)-pyridine-2-imines (3a–d) with various carboxylic acid derivatives (4a–g, 10 equiv.) in EtOH (10.0 mL) was scrutinized under microwave irradiation. It was observed that these reactions did not proceed smoothly without using additives, as in the case of acetic acid. After several optimization trials, the optimal reaction condition for acids (4b–g) other than acetic acid was established to be 3.0 mmol of 1-amino-pyridine-2-imines 3a–d with 4.0 mmol of carboxylic acid derivatives (4b–g) in EtOH (10.0 mL) containing acetic acid (5 equiv.) as catalyst, under microwave irradiation (Table 2). It is worth mentioning that, the amount of acetic acid should not exceed 5 equiv., otherwise the reaction between 1-amino-pyridine-2-imines (3a–d) and acetic acid will have occurred. As displayed in Table 2, the summarized results demonstrate that all the proposed reactions yielded their corresponding products (5a–k) in outstanding isolated yields without detecting by-products. Also, all the reactions were effectively afforded the desired products regardless of the substitution pattern of the aromatic moiety (Ar, Table 2). Further, the influence of the R-groups on reaction efficiency was also been investigated (Table 2). In this regard, electron-donating and electron-deficient groups are both acceptable in the present process. For instance, the substrates comprising cyano groups (Table 2, entries 4–6) were easily converted to the corresponding products in excellent yields. Besides, the current protocol has shown a good tolerance for both aromatic and aliphatic carboxylic acids (Table 2).
| Entry | Ar | R | Products | Yielda (%) |
|---|---|---|---|---|
| a Isolated yield.b Reaction conditions: a mixture of 1-amino-2(1H)-pyridine-2-imine derivatives (3a–d) (3.0 mmol) and acetic acid 4a (10 equiv.) in ethanol (10.0 mL) was charged in the glass tube of the microwave tube and irradiated at 100 °C for 15 min.c Reaction conditions: a mixture of 1-amino-2(1H)-pyridine-2-imine derivatives (3a–d) (3.0 mmol) and different carboxylic acids (4b–g) (4.0 mmol) in ethanol (10.0 mL), acetic acid (5 equiv.), was charged in the glass tube of the microwave tube and irradiated at 80 °C for 15 min. | ||||
| 1 | C6H5 | CH3 | ![]() |
92b |
| 2 | p-ClC6H4 | CH3 | ![]() |
87b |
| 3 | p-ClC6H4 | Cl–CH2 | ![]() |
91c |
| 4 | C6H5 | NC–CH2 | ![]() |
96c |
| 5 | p-ClC6H4 | NC–CH2 | ![]() |
97c |
| 6 | p-MeOC6H4 | NC–CH2 | ![]() |
94c |
| 7 | p-MeOC6H4 | ![]() |
![]() |
93c |
| 8 | p-MeOC6H4 | C6H5 | ![]() |
83c |
| 9 | p-ClC6H4 | C6H5 | ![]() |
86c |
| 10 | p-ClC6H4 | ![]() |
![]() |
87c |
| 11 | p-ClC6H4 | ![]() |
![]() |
84c |
Moreover, the proposed approach could also be successfully applied for carboxylic acid esters. For example when the diethyl oxalate (3.0 mmol) allowed to react with N-amino-2-iminopyridines (3a–e, 3.0 mmol) using 5 equiv. of acetic acid in EtOH (10.0 mL) under microwave irradiation at 100 °C for 15 min, the desired products (5l–p) were received in excellent yields (85–93%, Scheme 2). In these cyclization reactions, both electron-deficient and electron-rich Ar groups are also applicable. The cyclization reaction of electron-rich bearing substrates and diethyl oxalate, proceeded smoothly to produce the corresponding products (5m and 5n) in good yields (87 and 85% yield, respectively, Scheme 2). Similarly, in comparison to the unsubstituted aromatic derivative (5l), electron-deficient derivatives provided the respective products (5o and 5p) in excellent yields (92 and 93% yield, respectively, Scheme 2, Fig. 1 and 2).
![]() | ||
| Scheme 2 Substrate scope for the reaction of 1-amino-2-imino-pyridine derivatives (3a–e) with diethyl oxalate. | ||
Notably, 1,2,4-triazolo[1,5-a]pyridine-8-carbonitrile derivatives (5) could also be obtained through the cyclization reaction of derivatives 3c–d with either the corresponding aldehydes (6a–f) or with their arylidene malononitriles (7a–f) (Table 3, Fig. 3 and 4). These reactions were effectively performed with several aromatic aldehydes and their arylidenes comprising electron-withdrawing or electron-donating groups and afforded the corresponding products in comparable yields (Table 3). Also, aliphatic aldehydes such as chloroacetaldehyde yielded the targeted product in slightly lower yield in parallel to aromatic aldehydes (Table 3, entry 1). In comparison to carboxylic acids, the aldehydes or their arylidene malononitriles underwent the cyclization reaction at a fast rate with much more yields. Moreover, derivative 5t could be also obtained via refluxing of (E)-1-methyl-4-(2-nitrovinyl)benzene (8) with derivative 3d in CH3CN/DMF mixture (Scheme 3).
Likewise, compounds 5d–f could be also acquired via the cyclization reaction of derivatives 3a,c,d with (E)-3-(piperidin-1-yl)acrylonitrile (9) or with (E)-3-(dimethylamino)acrylonitrile (10) in superb yield (Scheme 4). Besides, this active methylene derivatives 5d–f underwent condensation reaction either with DMF–DMA or benzaldehyde easily to afford the isolable enamines 11a,b and arylidenes 12a,b, respectively (Scheme 4).
Further, the present approach was effectively applied also to isothiocyanate derivatives under moderate conditions. Thus, under microwave irradiation, 1,2-dihydropyridine-3-carbonitrile derivative (3d) underwent cyclization reaction when treated with phenyl isothiocyanate providing the unreported [1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile derivative (5v) in excellent yield (90%) (Scheme 5). In the course of this reaction, the sulfur of the isothiocyanate moiety gets lost presumably in the form of hydrogen sulfide gas. Therefore, the reaction may be started by the nucleophilic addition of the amino group of derivative 3d onto azomethine motif of phenyl isothiocyanate. Then, hydrogen sulfide was removed, possibly via an addition–elimination reaction, which results in a [1,2,4]triazolo[1,5-a]pyridine ring formation (Scheme 5, Fig. 5). Moreover, by boiling pyridine derivatives (3a,b,d) in DMF or glyoxalic acid, the unsubstituted triazole derivatives (5w–y) have been achieved in superb yields (89–91%, Scheme 5). In the latter reactions, the aldehydic group might be involved in cyclization reaction followed by the loss of dimethylamine (in case of DMF) or carbon dioxide (in the case of glyoxalic acid).
The aforesaid protocol also applied successfully for the bi-function aromatic aldehydic compounds. For example, the synthesis of bis-triazolopyridine derivatives (13a–c) was achieved through the cyclization reaction of the commercially available terephthalaldehyde with N-amino-2-imino-pyridine derivatives (3b,d,e) in 2
:
1 molar ratio (Scheme 6). Whereas, the mono-triazolopyridine derivative (5z), could be received on conducting the reaction between terephthalaldehyde and derivative 3d in 1
:
1 molar ratio (Scheme 6). Interestingly, the bis-derivative (13b) could be also synthesized via the reaction of the mono-derivative (5z), with another batch of 3d (1.0 mmol) (13b, Scheme 6).
Ultimately, the nicotinonitrile derivative (14) was produced under microwave irradiation in excellent yield (98%, Scheme 7, Fig. 6) on boiling compound 3d in EtOH containing a catalytic amount of TEA (triethylamine) or DBU (1,8-diazabicyclo[5.4.0]undec-7-ene).
The suggested structures of the synthesized mono- and bis-triazolopyridines have been verified based on several techniques of spectrometric analyses including 1H NMR and 13C NMR, in addition to the mass and accurate mass assignment. Moreover, the above structures were assured without any doubt through the X-ray single-crystal structure determination in some representative examples.
N); 1H NMR (400 MHz, DMSO-d6): δ 5.90 (d, J = 7.2 Hz, 1H, C–H6), 6.16 (s, 2H, NH2), 6.53 (brs, 1H, imine NH), 7.52–7.59 (m, 5H, Ar–H), 7.81 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 97.2, 101.6, 117.1, 127.8, 128.8, 130.1, 136.3, 143.1, 154.6, 155.1 ppm; MS (EI): m/z (%) 211 (M+ + 1, 18.25), 210 (M+, 100); HRMS (EI): m/z calcd for C12H10N4 (M+) 210.0899, found 210.0899.
N); 1H NMR (400 MHz, DMSO-d6): δ 2.38 (s, 3H, CH3), 5.88 (d, J = 7.2 Hz, 1H, C–H6), 6.13 (s, 2H, NH2), 6.58 (brs, 1H, imine NH), 7.34 (d, J = 8.0 Hz, 2H, Ar–H), 7.48 (d, J = 8.0 Hz, 2H, Ar–H), 7.79 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 20.9 (CH3), 101.6, 117.2, 127.7, 129.3, 133.3, 140.0, 142.6, 143.0, 154.6, 155.0 ppm; MS (EI): m/z (%) 225 (M+ + 1, 13.19), 224 (M+, 72.89); HRMS (EI): m/z calcd for C13H12N4 (M+) 224.1056, found 224.1055.
N); 1H NMR (400 MHz, DMSO-d6): δ 3.83 (s, 3H, OCH3), 5.89 (d, J = 6.8 Hz, 1H, C–H6), 6.11 (s, 2H, NH2), 6.55 (brs, 1H, imine NH), 7.08 (d, J = 8.4 Hz, 2H, Ar–H), 7.56 (d, J = 8.4 Hz, 2H, Ar–H), 7.76 ppm (d, J = 6.8 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 55.84 (OCH3), 101.99, 102.02, 114.65, 117.83, 128.66, 129.91, 143.27, 155.06, 155.23, 161.23 ppm; MS (EI): m/z (%) 241 (M+ + 1, 19.27), 240 (M+, 100); HRMS (EI): m/z calcd for C13H12N4O (M+) 240.1005, found 240.1005.
N); 1H NMR (400 MHz, DMSO-d6): δ 5.89 (d, J = 6.8 Hz, 1H, C–H6), 6.16 (s, 2H, NH2), 6.61 (brs, 1H, imine NH), 7.61–7.63 (m, 4H, Ar–H), 7.81 ppm (d, J = 6.8 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 101.3, 116.8, 128.8, 129.7, 134.8, 135.0, 143.1, 153.9, 154.3 ppm; MS (EI): m/z (%) 246 (M+ + 2, 34.29), 245 (M+ + 1, 17.94), 244 (M+, 100); HRMS (EI): m/z calcd for C12H9N4Cl (M+) 244.0510, found 244.0510.
N); 1H NMR (400 MHz, DMSO-d6): δ 5.90 (d, J = 6.8 Hz, 1H C–H6), 6.17 (s, 2H, NH2), 6.73 (brs, 1H, imine NH), 7.54 (d, J = 8.4 Hz, 2H, Ar–H), 7.74 (d, J = 8.4 Hz, 2H, Ar–H), 7.82 ppm (d, J = 6.8 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 102.2, 116.6, 123.7, 130.0, 131.8, 135.3, 143.4, 143.4, 154.2, 154.3 ppm; MS (EI): m/z (%) 290 (M+ + 2, 97.06), 289 (M+ + 1, 18.49), 288 (M+, 100); HRMS (EI): m/z calcd for C12H9N4Br (M+) 288.0005, found 288.0005.
:
1), as yellowish white crystals, yield: 0.65 g (92%), m.p. 155–156 °C; IR (KBr): ν/cm−1 2218 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 2.55 (s, 3H, CH3), 7.37 (d, J = 6.8 Hz, 1H, C–H6), 7.59–7.63 (m, 3H, Ar–H), 7.75 (d, J = 8.4 Hz, 2H, Ar–H) 9.19 ppm (d, J = 6.8 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.13 (CH3), 96.41, 114.61, 114.64, 128.78, 128.99, 130.18, 132.45, 135.47, 149.06, 150.30, 165.01 ppm; MS (EI): m/z (%) 235 (M+ + 1, 26.78), 234 (M+, 100). HRMS (EI): m/z calcd for C14H10N4 (M+) 234.0899, found 234.0898.
:
1), as buff crystals, yield: 0.70 g (87%), m.p. 225–226 °C; IR (KBr): ν/cm−1 2223 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 2.54 (s, 3H, CH3), 7.36 (d, J = 6.8 Hz, 1H, C–H6), 7.67 (d, J = 8.4 Hz, 2H, Ar–H), 7.76 (d, J = 8.4 Hz, 2H, Ar–H), 9.20 ppm (d, J = 6.8 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.1, 96.6, 114.5, 128.7, 129.1, 130.7, 132.6, 134.3, 135.2, 147.8, 150.2, 165.1 ppm; MS (EI): m/z (%) 270 (M+ + 2, 29.65), 269 (M+ + 1, 14.89), 268 (M+, 100). HRMS (EI): m/z calcd for C14H10ClN4 (M+) 268.1147, found 268.1147.
:
1), as beige crystals, yield: 0.80 g (91%) in case of acid, 0.75 g (85% in case of chloroacetaldehyde), m.p. 179–180 °C; IR (KBr): ν/cm−1 2239 (C
N); 1H NMR (600 MHz, CDCl3): δ 4.86 (s, 2H, CH2), 7.22 (d, J = 7.2 Hz, 1H, C–H6), 7.56 (d, J = 8.4 Hz, 2H, Ar–H), 7.64 (d, J = 8.4 Hz, 2H, Ar–H), 8.77 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, CDCl3): δ 37.36, 99.14, 113.49, 115.25, 129.70, 129.97, 131.50, 133.49, 137.26, 148.92, 151.00, 165.10 ppm; MS (EI): m/z (%) 304 (M+ + 2, 64.82), 303 (M+ + 1, 17.68), 302 (M+, 100). HRMS (EI): m/z calcd for C14H8Cl2N4 (M+) 302.01205, found 302.01205.
N); 1H NMR (400 MHz, DMSO-d6): δ 4.56 (s, 2H, CH2), 7.50 (d, J = 7.2 Hz, 1H, C–H6), 7.60–7.64 (m, 3H, Ar–H), 7.74–7.78 (m, 2H, Ar–H), 9.33 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.86, 97.44, 114.04, 115.70, 116.14, 128.62, 128.96, 130.26, 132.71, 135.39, 150.04, 150.74, 159.59 ppm; MS (EI): m/z (%) 260 (M+ + 1, 20.54), 259 (M+, 100). HRMS (EI): m/z calcd for C15H9N5 (M+) 259.0852, found 259.0853.
N); 1H NMR (400 MHz, DMSO-d6): δ 4.56 (s, 2H, CH2), 7.52 (d, J = 7.2 Hz, 1H, C–H6), 7.72 (d, J = 8.4 Hz, 2H, Ar–H), 7.81 (d, J = 8.4 Hz, 2H, Ar–H), 9.36 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.83, 97.36, 114.26, 115.60, 116.61, 129.12, 130.78, 133.09, 134.08, 135.43, 148.67, 150.56, 159.65 ppm; MS (EI): m/z (%) 295 (M+ + 2, 75.08), 294 (M+ + 1, 61.59), 293 (M+, 100). HRMS (EI): m/z calcd for C15H8ClN5 (M+) 293.0462, found 293.0462.
N); 1H NMR (600 MHz, DMSO-d6): δ 3.86 (s, 3H, OCH3), 4.52 (s, 2H, CH2), 7.17 (d, J = 9.0 Hz, 2H, Ar–H), 7.47 (d, J = 7.2 Hz, 1H, C–H6), 7.75 (d, J = 9.0 Hz, 2H, Ar–H), 9.26 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.79, 55.47, 96.12, 114.55, 114.70, 115.58, 116.62, 127.25, 130.52, 132.70, 149.60, 150.83, 159.38, 161.06 ppm; MS (EI): m/z (%) 290 (M+ + 1, 17.36), 289 (M+, 100). HRMS (EI): m/z calcd for C16H11N5O (M+) 289.0958, found 289.289.0957.
N); 1H NMR (600 MHz, DMSO-d6): δ 3.87 (s, 3H, OCH3), 4.57 (s, 2H, CH2), 7.18 (d, J = 9.0 Hz, 2H, Ar–H), 7.40 (d, J = 7.2 Hz, 1H, C–H6), 7.67 (d, J = 9.0 Hz, 2H, Ar–H), 7.74 (d, J = 9.0 Hz, 2H, Ar–H), 8.21 (d, J = 9.0 Hz, 2H, Ar–H), 9.21 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 33.99, 55.45, 95.94, 114.51, 114.90, 115.02, 123.56, 127.43, 130.34, 130.46, 132.53, 145.45, 146.36, 149.18, 150.65, 160.95, 166.03 ppm; MS (EI): m/z (%) 386 (M+ + 1, 24.83), 385 (M+, 100). HRMS (EI): m/z calcd for C21H15N5O3 (M+) 385.1169, found 385.1169.
:
3), as creamy white crystals, yield: 0.80 g (83%), m.p. 199–200 °C; IR (KBr): ν/cm−1 2221 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 3.88 (s, 3H, OCH3), 7.18 (d, J = 9.0 Hz, 2H, Ar–H), 7.43 (d, J = 7.2 Hz, 1H, C–H6), 7.56–7.59 (m, 3H, Ar–H), 7.77 (d, J = 9.0 Hz, 2H, Ar–H), 8.23–8.25 (m, 2H, Ar–H), 9.28 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 55.46, 96.09, 114.50, 114.99, 115.28, 127.03, 129.02, 129.63, 130.50, 130.74, 132.63, 149.15, 151.04, 160.94, 164.13 ppm; MS (EI): m/z (%) 327 (M+ + 1, 23.79), 326 (M+, 100). HRMS (EI): m/z calcd for C20H14N4O (M+) 326.1162, found 326.1162.
N); 1H NMR (600 MHz, DMSO-d6): δ 7.48 (d, J = 7.2 Hz, 1H, C–H6), 7.57–7.60 (m, 3H, Ar–H), 7.71 (d, J = 8.4 Hz, 2H, Ar–H), 7.81 (d, J = 8.4 Hz, 2H, Ar–H), 8.25–8.26 (m, 2H, Ar–H), 9.37 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.29, 114.53, 115.29, 127.10, 129.08, 129.54, 130.73, 130.87, 133.00, 134.25, 135.30, 148.22, 150.81, 164.54 ppm; MS (EI): m/z (%) 332 (M+ + 2, 40.03), 331 (M+ + 1, 30.11), 330 (M+, 100). HRMS (EI): m/z calcd for C19H11ClN4 (M+) 330.0666, found 330.0667.
N); 1H NMR (600 MHz, DMSO-d6): δ 6.99–7.04 (m, 2H, Ar–H), 7.41 (t, J = 7.8 Hz, 1H, Ar–H), 7.53 (d, J = 7.2 Hz, 1H, C–H6), 7.71 (d, J = 8.4 Hz, 2H, Ar–H), 7.81 (d, J = 8.4 Hz, 2H, Ar–H), 8.06 (d, J = 7.8 Hz, 1H, Ar–H), 9.37 (d, J = 7.2 Hz, 1H, C–H5), 10.87 ppm (s, 1H, OH); 13C{1H} NMR (150 MHz, DMSO-d6): δ 96.71, 112.76, 113.44, 115.39, 116.85, 119.28, 127.50, 128.65, 130.11, 132.10, 132.29, 133.65, 135.16, 148.29, 149.08, 156.82, 163.16 ppm; MS (EI): m/z (%) 348 (M+ + 2, 34.08), 347 (M+ + 1, 23.17), 346 (M+, 100). HRMS (EI): m/z calcd for C19H11ClN4O (M+) 346.0615, found 346.0614.
:
2), as creamy white crystals, yield: 0.86 g (84%), m.p. 215–216 °C; IR (KBr): ν/cm−1 3364, 3292 (NH2), 2221 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 5.01 (brs, 2H, NH2), 6.59 (d, J = 7.8 Hz, 1H, Ar–H), 6.73 (d, J = 7.2 Hz, 1H, C–H6), 6.95 (t, J = 7.8 Hz, 1H, Ar–H), 7.32 (t, J = 7.8 Hz, 1H, Ar–H), 7.43 (d, J = 7.8 Hz, 2H, Ar–H), 7.65 (d, J = 7.8 Hz, 2H, Ar–H), 7.95 (d, J = 7.8 Hz, 1H, Ar–H), 8.22 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.10, 110.26, 113.63, 114.80, 120.38, 121.30, 128.39, 129.58, 131.39, 131.89, 131.98, 141.44, 146.24, 147.34, 155.09, 158.35, 168.96 ppm; MS (EI): m/z (%) 347 (M+ + 2, 3.01), 346 (M+ + 1, 1.78), 345 (M+, 9.65). HRMS (EI): m/z calcd for C19H12ClN5 (M+) 345.0775, found 345.0776.
:
1), as white crystals, yield: 0.77 g (88%), m.p. 234–235 °C; IR (KBr): ν/cm−1 2231 (C
N), 1722 (CO); 1H NMR (400 MHz, DMSO-d6): δ 1.39 (t, J = 7.2 Hz, 3H, CH3CH2), 4.45 (q, J = 7.2 Hz, 2H, CH3CH2), 7.61–7.66 (m, 4H, pyridine C–H6 and 3 Ar–H), 7.79–7.82 (m, 2H, Ar–H), 9.42 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, CDCL3): δ 14.19 (CH3), 62.79 (CH2), 100.15, 113.13, 117.18, 128.65, 129.34, 130.86, 131.64, 134.82, 150.81, 151.08, 157.46, 159.49 ppm; MS (EI): m/z (%) 293 (M+ + 1, 3.24), 292 (M+, 16.04). HRMS (EI): m/z calcd for C16H12N4O2 (M+) 292.0954, found 292.0954.
:
1), as white crystals, yield: 0.80 g (87%), m.p. 180–181 °C; IR (KBr): ν/cm−1 2230 (C
N), 1726 (C
O); 1H NMR (400 MHz, DMSO-d6): δ 1.38 (t, J = 7.2 Hz, 3H, CH3CH2), 2.43 (s, 3H, CH3), 4.45 (q, J = 7.2 Hz, 2H, CH3CH2), 7.45 (d, J = 8.0 Hz, 2H, Ar–H), 7.61 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.70 (d, J = 8.0 Hz, 2H, Ar–H), 9.38 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 14.06, 20.96 (2CH3), 61.99 (CH2), 97.99, 114.41, 117.32, 128.86, 129.74, 132.23, 133.47, 140.73, 150.49, 150.60, 156.19, 159.37 ppm; MS (EI): m/z (%) 307 (M+ + 1, 7.09), 306 (M+, 37.28). HRMS (EI): m/z calcd for C17H14N4O2 (M+) 306.1111, found 306.1111. Crystal data, moiety formula: C17H14N4O2, M = 306.32, monoclinic, a = 16.043(2) Å, b = 9.9874(9) Å, c = 18.960(2) Å, V = 2972.1(5) Å3, α = γ = 90°, β = 101.956(8)°, space group: P21/c (#14), Z = 8, Dcalc = 1.369 g cm−3, no. of reflection measured = 5132, 2θmax = 50.10°, R1 = 0.0638 (CCDC 1982378†).35
:
1), as white crystals, yield: 0.82 g (85%), m.p. 184–185 °C; IR (KBr): ν/cm−1 2231 (C
N), 1732 (C
O); 1H NMR (400 MHz, DMSO-d6): δ 1.38 (t, J = 7.2 Hz, 3H, CH3CH2), 3.86 (s, 3H, OCH3), 4.43 (q, J = 7.2 Hz, 2H, CH3CH2), 7.17 (d, J = 8.8 Hz, 2H, Ar–H), 7.59 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.76 (d, J = 8.8 Hz, 2H, Ar–H), 9.32 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (100 MHz, DMSO-d6): δ 14.47, 55.96 (2CH3), 62.40 (CH2), 97.66, 115.03, 117.65, 127.45, 131.05, 133.67, 150.61, 150.97, 156.55, 159.77, 161.65 ppm; MS (EI): m/z (%) 323 (M+ + 1, 8.65), 322 (M+, 43.39). HRMS (EI): m/z calcd for C17H14N4O3 (M+) 322.1060, found 322.1060.
:
3), as white crystals, yield: 0.90 g (92%), m.p. 218–219 °C; IR (KBr): ν/cm−1 2231 (C
N), 1735 (C
O); 1H NMR (600 MHz, DMSO-d6): δ 1.38 (t, J = 7.2 Hz, 3H, CH3CH2), 4.44 (q, J = 7.2 Hz, 2H, CH3CH2), 7.65 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.72 (d, J = 8.4 Hz, 2H, Ar–H), 7.82 (d, J = 8.4 Hz, 2H, Ar–H), 9.43 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.05 (CH3), 62.03 (CH2), 98.69, 114.13, 117.23, 129.22, 130.85, 133.68, 133.91, 135.64, 149.33, 150.30, 156.28, 159.30 ppm; MS (EI): m/z (%) 328 (M+ + 2, 6.34), 327 (M+ + 1, 3.57), 326 (M+, 17.29). HRMS (EI): m/z calcd for C16H11ClN4O2 (M+) 326.0565, found 326.0565.
:
3), as white crystals, yield: 1.00 g (92%), m.p. 229–230 °C; IR (KBr): ν/cm−1 2231 (C
N), 1733 (C
O); 1H NMR (400 MHz, DMSO-d6): δ 1.38 (t, J = 7.2 Hz, 3H, CH3CH2), 4.45 (q, J = 7.2 Hz, 2H, CH3CH2), 7.65 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.75 (d, J = 8.4 Hz, 2H, Ar–H), 7.87 (d, J = 8.4 Hz, 2H, Ar–H), 9.43 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.07 (CH3), 62.05 (CH2), 98.66, 114.16, 117.18, 124.48, 131.05, 132.17, 133.72, 134.31, 149.44, 150.33, 156.30, 159.33 ppm; MS (EI): m/z (%) 372 (M+ + 2, 24.53), 371 (M+ + 1, 5.12), 370 (M+, 24.85). HRMS (EI): m/z calcd for C16H11BrN4O2 (M+) 370.0059, found 370.0058. Crystal data, moiety formula: C16H11BrN4O2, M = 371.19, orthorhombic, a = 13.845(2) Å, b = 7.528(1) Å, c = 30.459(4) Å, V = 3174.7(8) Å3, α = β = γ = 90°, space group: Pbca (#61), Z = 8, Dcalc = 1.553 g cm−3, no. of reflection measured = 2742, 2θmax = 49.9°, R1 = 0.0807 (CCDC 1982379†).35
:
1), as creamy white crystals, yield: 0.95 g (90%), m.p. 224–225 °C; IR (KBr): ν/cm−1 2229 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 3.89 (s, 3H, OCH3), 7.17 (d, J = 8.4 Hz, 2H, Ar–H), 7.39 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.60 (d, J = 8.4 Hz, 2H, Ar–H), 7.75 (d, J = 8.4 Hz, 2H, Ar–H), 8.22 (d, J = 8.4 Hz, 2H, Ar–H), 9.17 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 55.10 (OCH3), 96.03, 114.14, 114.24, 114.98, 127.15, 128.28, 128.40, 128.60, 129.88, 131.97, 135.12, 148.95, 150.75, 160.77, 163.21 ppm; MS (EI): m/z (%) 362 (M+ + 2, 30.89), 361 (M+ + 1, 20.56), 360 (M+, 100.00). HRMS (EI): m/z calcd for C20H13ClN4O (M+) 360.0772, found 360.0772. Crystal data, moiety formula: C20H13ClN4O, C3H7NO, sum formula: C23H20ClN5O2, M = 433.90, orthorhombic, a = 22.8101(9) Å, b = 7.5155(3) Å, c = 24.720(2) Å, V = 4237.7(4) Å3, α = β = γ = 90°, space group: Pca21 (#29), Z = 8, Dcalc = 1.360 g cm−3, no. of reflection measured = 3817, 2θmax = 50.1°, R1 = 0.0428 (CCDC 1982380†).35
N); 1H NMR (600 MHz, DMSO-d6): δ 3.86 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 7.12 (d, J = 8.4 Hz, 2H, Ar–H), 7.18 (d, J = 9.0 Hz, 2H, Ar–H), 7.40 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.78 (d, J = 8.4 Hz, 2H, Ar–H), 8.18 (d, J = 9.0 Hz, 2H, Ar–H), 9.25 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 55.33, 55.46 (2OCH3), 95.80, 114.45, 114.51, 114.96, 115.07, 122.05, 127.52, 128.71, 130.45, 132.50, 148.97, 151.07, 160.93, 161.30, 164.36 ppm; MS (EI): m/z (%) 357 (M+ + 1, 24.09), 356 (M+, 100.00). HRMS (EI): m/z calcd for C21H16N4O2 (M+) 356.1267, found 356.1266.
N); 1H NMR (600 MHz, DMSO-d6): δ 7.49 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.66 (d, J = 7.8 Hz, 2H, Ar–H), 7.71 (d, J = 7.8 Hz, 2H, Ar–H), 7.81 (d, J = 7.8 Hz, 2H, Ar–H), 8.26 (d, J = 7.8 Hz, 2H, Ar–H), 9.37 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.22, 113.87, 115.10, 128.24, 128.57, 128.73, 128.82, 130.27, 132.55, 133.96, 135.06, 135.33, 148.10, 150.60, 163.46 ppm; MS (EI): m/z (%) 366 (M+ + 2, 59.97), 365 (M+ + 1, 24.36), 364 (M+, 100.00). HRMS (EI): m/z calcd for C20H13ClN4O (M+) 360.0772, found 360.0774.
N); 1H NMR (600 MHz, DMSO-d6): δ 2.39 (s, 3H, CH3), 7.37 (d, J = 8.4 Hz, 2H, Ar–H), 7.44 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.71 (d, J = 8.4 Hz, 2H, Ar–H), 7.80 (d, J = 8.4 Hz, 2H, Ar–H), 8.12 (d, J = 8.4 Hz, 2H, Ar–H), 9.32 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 21.05 (CH3), 97.12, 114.56, 115.12, 126.79, 127.07, 129.08, 129.65, 130.73, 132.92, 134.28, 135.27, 140.73, 148.09, 150.78, 164.66 ppm; MS (EI): m/z (%) 346 (M+ + 2, 33.47), 345 (M+ + 1, 27.19), 344 (M+, 100.00). HRMS (EI): m/z calcd for C20H13ClN4 (M+) 344.0823, found 344.0823.
N); 1H NMR (600 MHz, DMSO-d6): δ 7.39–7.47 (m, 5H, Ar–H), 7.72 (d, J = 8.4 Hz, 2H, Ar–H), 7.81–7.89 (m, 5H, Ar–H), 9.29 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 96.83, 114.59, 114.98, 116.97, 127.54, 128.87, 129.08, 129.26, 130.73, 132.78, 134.30, 135.28, 135.43, 137.41, 148.23, 150.43, 164.45 ppm; MS (EI): m/z (%) 358 (M+ + 2, 17.05), 357 (M+ + 1, 38.14), 356 (M+, 47.89), 355 (M+ − 1, 100.00). HRMS (EI): m/z calcd for C21H13ClN4 (M+) 356.0823, found 356.0823. Crystal data, moiety formula: C21H13ClN4, M = 356.81, monoclinic, a = 7.653(1) Å, b = 6.928(9) Å, c = 32.82(4) Å, V = 1734(4) Å3, α = γ = 90°, β = 94.79(3)°, space group: P21/n (#14), Z = 4, Dcalc = 1.367 g cm−3, no. of reflection measured = 3041, 2θmax = 50.10°, R1 = 0.0800 (CCDC 1982381†).35
:
2), as yellow crystals, yield: 0.95 g (91%), m.p. 216–218 °C; IR (KBr): ν/cm−1 3362 (NH), 2225 (2C
N); 1H NMR (400 MHz, DMSO-d6): δ 6.92 (t, J = 7.8 Hz, 1H, Ar–H), 7.17 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.31 (t, J = 7.8 Hz, 2H, Ar–H), 7.63 (d, J = 8.4 Hz, 2H, Ar–H), 7.68 (d, J = 7.8 Hz, 2H, Ar–H), 7.74 (d, J = 8.4 Hz, 2H, Ar–H), 9.07 (d, J = 7.2 Hz, 1H, C–H5), 10.09 ppm (s, 1H, NH); 13C{1H} NMR (150 MHz, DMSO-d6): δ 93.95, 112.72, 114.76, 116.86, 120.75, 128.77, 128.95, 130.52, 131.82, 134.49, 134.98, 140.42, 146.95, 149.72, 163.23 ppm; MS (EI): m/z (%) 347 (M+ + 2, 33.07), 346 (M+ + 1, 48.39), 345 (M+, 100.00). HRMS (EI): m/z calcd for C19H12ClN5 (M+) 345.0775, found 345.0775. Crystal data, moiety formula: C19H12ClN5, M = 345.79, triclinic, a = 8.9886(8) Å, b = 12.8468(10) Å, c = 15.1372(12) Å, V = 1635.2(2) Å3, α = 71.352(4)°, β = 80.896(4)°, γ = 86.548(5)°, space group: P
, Z = 4, Dcalc = 1.405 g cm−3, no. of reflection measured = 5570, θmax = 66.470°, R1 = 0.0441 (CCDC 1982382†).35
:
1), as yellow crystals, yield: 0.55 g (84%), m.p. 159–160 °C; IR (KBr): ν/cm−1 2221 (C
N); 1H NMR (400 MHz, DMSO-d6): δ 7.49 (d, J = 7.2 Hz, 1H, C–H6), 7.62–7.67 (m, 3H, Ar–H), 7.79 (d, J = 8.4 Hz, 2H, Ar–H), 8.75 (s, 1H, C–H) 9.35 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.60, 114.41, 115.56, 128.85, 129.03, 130.28, 133.27, 135.40, 149.60, 149.68, 155.40 ppm; MS (EI): m/z (%) 221 (M+ + 1, 17.65), 220 (M+, 100). HRMS (EI): m/z calcd for C13H8N4 (M+) 220.0743, found 220.0743.
:
1), as yellow crystals, yield: 0.65 g (85%), m.p. above 300 °C; IR (KBr): ν/cm−1 2226 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 7.48 (d, J = 7.2 Hz, 1H), 7.70 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 8.4 Hz, 2H), 8.75 (s, 1H), 9.35 ppm (d, J = 7.2 Hz, 1H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.8, 114.4, 115.4, 129.1, 130.8, 133.2, 134.2, 135.3, 148.3, 149.6, 155.5 ppm; MS (EI): m/z (%) 256 (M+ + 2, 33.19), 255 (M+ + 1, 16.29), 254 (M+, 100). HRMS (EI): m/z calcd for C13H7ClN4 (M+) 254.1147, found 254.1147.
:
1), as yellowish white crystals, yield: 0.60 g (83%), m.p. 172–173 °C; IR (KBr): ν/cm−1 2224 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 2.40 (s, 3H, CH3), 7.40 (d, J = 7.8 Hz, 2H, Ar–H), 7.42 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.65 (d, J = 7.8 Hz, 2H, Ar–H), 8.70 (s, 1H, C–H2), 9.28 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 20.87 (CH3), 97.15, 114.63, 115.46, 128.73, 129.58, 132.47, 132.94, 140.29, 149.55 149.73, 155.31 ppm; MS (EI): m/z (%) 235 (M+ + 1, 13.94), 234 (M+, 100). HRMS (EI): m/z calcd for C14H10N4 (M+) 234.0899, found 234.0898.
:
1), as orange crystals, yield: 1.00 g (92%), m.p. 276–277 °C; IR (KBr): ν/cm−1 2231 (C
N), 1695 (C
O); 1H NMR (600 MHz, DMSO-d6): δ 7.54 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.74 (d, J = 8.4 Hz, 2H, Ar–H), 7.84 (d, J = 8.4 Hz, 2H, Ar–H), 8.12 (d, J = 8.4 Hz, 2H, Ar–H), 8.48 (d, J = 8.4 Hz, 2H, Ar–H), 9.41 (d, J = 7.2 Hz, 1H, C–H5), 10.12 ppm (s, 1H, CHO); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.41, 113.55, 115.20, 127.32, 128.56, 129.44, 130.06, 132.40, 133.81, 134.41, 135.01, 137.31, 148.15, 150.54, 163.29, 191.82 ppm; MS (EI): m/z (%) 360 (M+ + 2, 31.05), 359 (M+ + 1, 41.58), 358 (M+, 100). HRMS (EI): m/z calcd for C20H11ClN4O (M+) 358.0615, found 358.0615.
:
3), as yellowish white crystals, yield: 0.85 g (90%), m.p. 279–280 °C; IR (KBr): ν/cm−1 2227, 2202 (2C
N); 1H NMR (600 MHz, DMSO-d6): δ 3.36 (s, 6H, 2CH3), 7.29 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.60–7.62 (m, 3H, Ar–H), 7.73–7.76 (m, 2H, Ar–H), 7.98 (s, 1H, enamine C–H), 9.14 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 30.55, 49.89 (2CH3), 65.96, 95.00, 113.45, 114.04, 117.91, 128.11, 128.39, 129.48, 131.31, 135.31, 148.43, 150.07, 153.27, 165.03 ppm; MS (EI): m/z (%) 315 (M+ + 1, 47.38), 314 (M+, 100.00). HRMS (EI): m/z calcd for C18H14N6 (M+) 314.1274, found 314.1274.
N); 1H NMR (400 MHz, DMSO-d6): δ 3.36 (s, 6H, 2CH3), 7.31 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.69 (d, J = 8.4 Hz, 2H, Ar–H), 7.78 (d, J = 8.4 Hz, 2H, Ar–H), 7.99 (s, 1H, enamine C–H), 9.17 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 30.42, 50.07 (2CH3), 66.32, 95.57, 113.79, 114.40, 118.40, 128.96, 130.49, 131.91, 134.56, 135.19, 147.58, 150.46, 153.78, 165.62 ppm; MS (EI): m/z (%) 350 (M+ + 2, 31.57), 349 (M+ + 1, 29.98), 348 (M+, 100.00). HRMS (EI): m/z calcd for C18H13ClN6 (M+) 348.0884, found 348.0884.
:
1), as yellowish white crystals, yield: 1.00 g (89%), m.p. 257–258 °C; IR (KBr): ν/cm−1 2225, 2208 (2C
N); 1H NMR (600 MHz, DMSO-d6): δ 3.88 (s, 3H, OCH3), 7.20 (d, J = 8.4 Hz, 2H, Ar–H), 7.52 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.61–7.62 (m, 3H, Ar–H), 7.79 (d, J = 8.4 Hz, 2H, Ar–H), 8.13–8.14 (m, 2H, Ar–H), 8.58 (s, 1H, arylidene C–H), 9.34 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, TFA-d): δ 57.46 (OCH3), 68.17, 95.42, 95.65, 117.90, 122.64, 128.22, 131.88, 133.19, 133.22, 133.58, 135.79, 137.64, 148.82, 157.48, 159.06, 159.79, 165.53 ppm; MS (EI): m/z (%) 378 (M+ + 1, 53.67), 377 (M+, 53.67), 376 (M+ − 1, 100.00). HRMS (EI): m/z calcd for C23H15N5O (M+) 377.1271, found 377.1270.
N); 1H NMR (600 MHz, DMSO-d6): δ 7.49 (d, J = 7.2 Hz, 1H, pyridine C–H6), 7.60–761 (m, 3H, Ar–H), 7.69 (d, J = 8.4 Hz, 2H, Ar–H), 7.80 (d, J = 8.4 Hz, 2H, Ar–H), 8.10–8.11 (m, 2H, Ar–H), 8.57 (s, 1H, arylidene C–H), 9.30 ppm (d, J = 7.2 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.20, 101.09, 113.50, 115.28, 115.43, 128.61, 128.66, 129.48, 130.13, 131.55, 132.09, 132.52, 133.72, 135.12, 148.06, 148.67, 150.25, 160.90 ppm; MS (EI): m/z (%) 383 (M+ + 2, 62.87), 382 (M+ + 1, 36.81), 381 (M+, 100), HRMS (EI): m/z calcd for C22H12ClN5 (M+) 381.0775, found 381.0775.
N); 1H NMR (600 MHz, TFA-d): δ 2.59 (s, 6H. 2CH3), 7.60 (d, J = 8.4 Hz, 4H, Ar–H), 7.83 (d, J = 8.4 Hz, 4H, Ar–H), 8.07 (d, J = 7.2 Hz, 2H, C–H5), 8.69 (s, 4H, Ar–H), 9.26 ppm (d, J = 7.2 Hz, 2H, C–H6); 13C{1H} NMR (150 MHz, TFA-d): δ 21.05 (CH3), 94.85, 112.61, 122.40, 128.34, 129.79, 130.52, 130.94, 131.79, 135.20, 146.78, 156.93, 160.24 ppm; MS (EI): m/z (%) 543 (M+ + 1, 37.19), 542 (M+, 100). HRMS (EI): m/z calcd for C34H22N8 (M+) 542.1961, found 542.1961.
N); 1H NMR (600 MHz, TFA-d): δ 7.68 (d, J = 8.4 Hz, 4H, Ar–H), 7.79 (d, J = 8.4 Hz, 4H, Ar–H), 7.79 (d, J = 7.2 Hz, 2H, C–H5), 8.62 (s, 4H, Ar–H), 9.24 ppm (d, J = 7.2 Hz, 2H, C–H6); 13C{1H} NMR (150 MHz, TFA-d): δ 95.88, 112.17, 122.16, 128.41, 130.55, 130.99, 131.42, 132.20, 135.56, 141.71, 146.73, 157.40, 158.56 ppm; MS (EI): m/z (%) 584 (M+ + 2, 71.23), 583 (M+ + 1, 42.09), 582 (M+, 100). HRMS (EI): m/z calcd for C32H16Cl2N8 (M+) 582.0869, found 582.0869.
N); 1H NMR (600 MHz, TFA-d): δ 7.75 (d, J = 8.4 Hz, 4H, Ar–H), 7.90 (d, J = 8.4 Hz, 4H, Ar–H), 8.01 (d, J = 7.2 Hz, 2H, C–H5), 8.66 (s, 4H, Ar–H), 9.29 ppm (d, J = 7.2 Hz, 2H, C–H6); 13C{1H} NMR (150 MHz, TFA-d): δ 95.87, 122.06, 128.48, 129.88, 130.58, 130.97, 132.62, 134.57, 135.56, 146.85, 157.52, 158.68 ppm; MS (EI): m/z (%) 672 (M+ + 2, 56.78), 671 (M+ + 1, 15.94), 670 (M+, 27.15). HRMS (EI): m/z calcd for C32H16Br2N8 (M+) 669.9859, found 669.9859.
:
1), as yellow crystals, yield: 0.70 g (98%), m.p. 217–218 °C; IR (KBr): ν/cm−1 3462, 3317 (NH2), 2210 cm−1 (C
N); 1H NMR (600 MHz, DMSO-d6): δ 6.70 (d, J = 5.4 Hz, 1H, pyridine C–H6), 6.99 (s, 2H, NH2), 7.60 (s, 4H, Ar–H), 8.23 ppm (d, J = 5.4 Hz, 1H, C–H5); 13C{1H} NMR (150 MHz, DMSO-d6): δ 87.58, 112.26, 116.50, 128.81, 130.05, 134.49, 135.47, 152.56, 152.78, 161.07 ppm; MS (EI): m/z (%) 231 (M+ + 2, 28.16), 230 (M+ + 1, 16.32), 229 (M+, 100). HRMS (EI): m/z calcd for C12H8ClN3 (M+) 229.0401, found 229.0401, Crystal data, moiety formula: C12H8ClN3, M = 229.67, monoclinic, a = 3.8851(9) Å, b = 19.350(4) Å, c = 14.116(3) Å, V = 1055.5(4) Å3, α = γ = 90°, β = 95.964(7)°, space group: P21/c (#14), Z = 4, Dcalc = 1.445 g cm−3, no. of reflection measured = 1863, 2θmax = 50.0°, R1 = 0.0782 (CCDC 1982383†).35
studies of the solvothermal ligand reactions, network topologies, and photoluminescence properties, J. Am. Chem. Soc., 2005, 127, 5495–5506 CrossRef CAS PubMed.Footnote |
| † CCDC 1982378–1982383 and crystal data for compounds 5m (CIF), 5p (CIF), 5q (CIF), 5u (CIF), 5v (CIF), 14 (CIF). For crystallographic data in CIF or other electronic format see DOI: 10.1039/d0ra02256j |
| This journal is © The Royal Society of Chemistry 2020 |